As of 2025-07-09, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (99.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.65 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -2247.6%.
The range of the Relative Valuation is (95.23) - (114.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 15.9x | 11.1x |
| Forward P/E multiples | 13.2x - 21.0x | 16.5x |
| Fair Price | (95.23) - (114.77) | (99.86) |
| Upside | -2148.0% - -2568.1% | -2247.6% |
| Date | P/E |
| 2025-07-08 | -0.64 |
| 2025-07-07 | -0.58 |
| 2025-07-03 | -0.61 |
| 2025-07-02 | -0.64 |
| 2025-07-01 | -0.60 |
| 2025-06-30 | -0.60 |
| 2025-06-27 | -0.61 |
| 2025-06-26 | -0.62 |
| 2025-06-25 | -0.62 |
| 2025-06-24 | -0.64 |
| 2025-06-23 | -0.60 |
| 2025-06-20 | -0.61 |
| 2025-06-18 | -0.61 |
| 2025-06-17 | -0.60 |
| 2025-06-16 | -0.63 |
| 2025-06-13 | -0.61 |
| 2025-06-12 | -0.60 |
| 2025-06-11 | -0.61 |
| 2025-06-10 | -0.61 |
| 2025-06-09 | -0.58 |
| 2025-06-06 | -0.62 |
| 2025-06-05 | -0.59 |
| 2025-06-04 | -0.60 |
| 2025-06-03 | -0.59 |
| 2025-06-02 | -0.57 |
| 2025-05-30 | -0.58 |
| 2025-05-29 | -0.63 |
| 2025-05-28 | -0.62 |
| 2025-05-27 | -0.63 |
| 2025-05-23 | -0.63 |
| 2025-05-22 | -0.64 |
| 2025-05-21 | -0.65 |
| 2025-05-20 | -0.71 |
| 2025-05-19 | -0.71 |
| 2025-05-16 | -0.74 |
| 2025-05-15 | -0.75 |
| 2025-05-14 | -0.67 |
| 2025-05-13 | -0.68 |
| 2025-05-12 | -0.85 |
| 2025-05-09 | -0.83 |
| 2025-05-08 | -0.85 |
| 2025-05-07 | -0.84 |
| 2025-05-06 | -0.87 |
| 2025-05-05 | -0.98 |
| 2025-05-02 | -1.02 |
| 2025-05-01 | -0.93 |
| 2025-04-30 | -0.93 |
| 2025-04-29 | -0.88 |
| 2025-04-28 | -0.84 |
| 2025-04-25 | -0.78 |